Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shamsah B Sonawalla

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Dialogues in Clinical Neuroscience|October 29, 2011
Placebo response in depressionShamsah B Sonawalla, Jerrold F Rosenbaum
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 10, 2002
Early drop-outs, late drop-outs and completers: differences in the continuation phase of a clinical trialShamsah B Sonawalla, Amy H Farabaugh, Vinita M Leslie, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 28, 2002
Early drop-outs, late drop-outs and completers: differences in the continuation phase of a clinical trialShamsah B Sonawalla, Amy H Farabaugh, Vinita M Leslie, et al.
Human Psychopharmacology|June 20, 2006
Differences in cognitive factors between "true drug" versus "placebo pattern" response to fluoxetine as defined by pattern analysisAmy H Farabaugh, Shamsah B Sonawalla, Maurizio Fava, et al.
Psychiatry Research|December 13, 2002
An open pilot study of nefazodone in depression with anger attacks: relationship between clinical response and receptor bindingDavid Mischoulon, Darin D Dougherty, Kathryn A Bottonari, et al.
Psychiatry Research|May 22, 2003
Somatic symptoms in treatment-resistant depressionGeorge I Papakostas, Timothy Petersen, John Denninger, et al.
Journal of Psychopharmacology (Oxford, England)|September 19, 2002
Fluoxetine treatment of depressed patients with comorbid anxiety disordersShamsah B Sonawalla, Amy Farabaugh, Mary W Johnson, et al.
Neuropsychobiology|May 22, 2003
Serum cholesterol in treatment-resistant depressionGeorge I Papakostas, Timothy Petersen, Shamsah B Sonawalla, et al.
Psychosomatics|August 22, 2002
Elevated cholesterol levels associated with nonresponse to fluoxetine treatment in major depressive disorderShamsah B Sonawalla, George I Papakostas, Timothy J Petersen, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 10, 2008
A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorderDavid Mischoulon, Catherine Best-Popescu, Michael Laposata, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Dialogues in Clinical Neuroscience|October 29, 2011
Placebo response in depressionShamsah B Sonawalla, Jerrold F Rosenbaum
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 10, 2002
Early drop-outs, late drop-outs and completers: differences in the continuation phase of a clinical trialShamsah B Sonawalla, Amy H Farabaugh, Vinita M Leslie, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 28, 2002
Early drop-outs, late drop-outs and completers: differences in the continuation phase of a clinical trialShamsah B Sonawalla, Amy H Farabaugh, Vinita M Leslie, et al.
Human Psychopharmacology|June 20, 2006
Differences in cognitive factors between "true drug" versus "placebo pattern" response to fluoxetine as defined by pattern analysisAmy H Farabaugh, Shamsah B Sonawalla, Maurizio Fava, et al.
Psychiatry Research|December 13, 2002
An open pilot study of nefazodone in depression with anger attacks: relationship between clinical response and receptor bindingDavid Mischoulon, Darin D Dougherty, Kathryn A Bottonari, et al.
Psychiatry Research|May 22, 2003
Somatic symptoms in treatment-resistant depressionGeorge I Papakostas, Timothy Petersen, John Denninger, et al.
Journal of Psychopharmacology (Oxford, England)|September 19, 2002
Fluoxetine treatment of depressed patients with comorbid anxiety disordersShamsah B Sonawalla, Amy Farabaugh, Mary W Johnson, et al.
Neuropsychobiology|May 22, 2003
Serum cholesterol in treatment-resistant depressionGeorge I Papakostas, Timothy Petersen, Shamsah B Sonawalla, et al.
Psychosomatics|August 22, 2002
Elevated cholesterol levels associated with nonresponse to fluoxetine treatment in major depressive disorderShamsah B Sonawalla, George I Papakostas, Timothy J Petersen, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 10, 2008
A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorderDavid Mischoulon, Catherine Best-Popescu, Michael Laposata, et al.
Pageof 2